Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study

Table 2 Multivariate logistic regression for all IFDs and for aspergillosis (significance level p ≤ 0.05)

Risk factors	AOR	all IFDs			Aspergillosis
Risk factors	AOR	95 % CI	p-value	AOR	95 % CI	p-value
Intensified GvHD therapy	3.6	1.3–9.9	0.01	5.4	1.7–17.3	0.01
TMA	3.7	1.1–12.9	0.04	6.7	1.7–26.3	0.01
Antifungal prophylaxis	0.3	0.1–0.8	0.02	0.2	0.03–0.9	0.03
Sex (female)	ns	ns	ns	x	x	x
EBMT score >2	ns	ns	ns	x	x	x
Lymphoma	x	x	x	ns	ns	ns

Abbreviations: AOR adjusted odds ratio, CI confidence interval, IFD invasive fungal disease, GvHD graft-versus-host disease, TMA transplant-associated microangiopathy, EBMT European Society for Blood and Marrow Transplantation, ns not significant, x not included in the model

ISSN: 1471-2334